Trial Profile
Combining Abraxane With Capecitabine and Radiation Therapy for Consolidation of Treatment Following Induction Chemotherapy for Locally Advanced Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Sep 2022
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Capecitabine
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions
- 31 Aug 2022 Status changed from active, no longer recruiting to completed.
- 02 Feb 2022 Planned primary completion date changed from 30 Nov 2021 to 30 Nov 2022.
- 15 Jul 2021 Planned End Date changed from 30 Nov 2020 to 30 Nov 2022.